Supreme Court Showdown Over Glyphosate: How a Weed Killer Is Testing the MAHA-Trump Alliance
The U.S. Supreme Court heard arguments Monday in a case that could reshape the legal landscape for one of the world’s most widely used herbicides—and in the process, strain the fragile alliance between President Donald Trump and the Develop America Healthy Again (MAHA) movement. At stake: whether federal law preempts state-level lawsuits alleging that glyphosate, the active ingredient in Bayer’s Roundup, causes cancer. The decision, expected by June, arrives as Congress debates a farm bill that would further shield the chemical from litigation, setting up a high-stakes clash between agricultural interests and a grassroots health movement that helped deliver Trump’s reelection.
Key Takeaways
- The Supreme Court is weighing whether federal pesticide regulations block state lawsuits over glyphosate’s alleged cancer risks.
- The case pits Bayer, the maker of Roundup, against plaintiffs who claim the herbicide caused their non-Hodgkin lymphoma.
- The MAHA movement, which advocates for reduced chemical use in agriculture, views the case as a referendum on its influence in Washington.
- A separate farm bill, expected to pass the House this week, includes provisions that would limit future glyphosate lawsuits.
- The outcome could determine the fate of thousands of pending cases and shape the future of pesticide regulation in the U.S.
The Legal Battle Over Glyphosate
The Supreme Court case, Bayer v. Hardeman, centers on Edwin Hardeman, a California man who alleges that decades of Roundup use caused his non-Hodgkin lymphoma. A jury initially awarded Hardeman $80 million in damages, though the amount was later reduced. Bayer, which acquired Monsanto—the original manufacturer of Roundup—in 2018, argues that federal law preempts such state-level claims since the Environmental Protection Agency (EPA) has repeatedly approved glyphosate as safe when used as directed.
During Monday’s oral arguments, justices appeared divided. Some questioned whether the EPA’s approval of glyphosate’s labeling should shield Bayer from lawsuits, while others expressed concern about limiting consumers’ ability to seek redress for alleged harm. Justice Elena Kagan noted that the case could set a precedent for how courts handle conflicts between federal regulations and state tort law, particularly in cases involving widely used chemicals.
The outcome could affect thousands of similar lawsuits. Bayer has already settled more than 100,000 Roundup-related claims for roughly $11 billion, but an estimated 30,000 cases remain unresolved, according to court filings. A ruling in Bayer’s favor would likely bar most future claims, while a decision for Hardeman could open the floodgates for additional litigation.
The MAHA Movement’s Stake in the Fight
The Make America Healthy Again movement, a coalition of health advocates, environmental activists, and wellness influencers, has made reducing glyphosate use a central priority. The group gained prominence during the 2024 election cycle, when its preferred presidential candidate, Robert F. Kennedy Jr., dropped out of the race and endorsed Trump. Kennedy, now the Secretary of Health and Human Services, has been a vocal critic of glyphosate, citing studies linking the chemical to cancer and other health issues.
MAHA’s influence was on full display earlier this month when a group of activists, including surgeon general nominee Casey Means, met with White House officials to discuss pesticide risks. The meeting, described as a “jam-packed” session by attendee Alex Clark—a MAHA-aligned influencer—featured Kennedy, White House Chief of Staff Susie Wiles, and even a brief appearance by Trump himself. Clark, who hosts the Culture Apothecary podcast, said the administration “let us get everything off our chest” regarding glyphosate’s perceived dangers.
The Supreme Court case has galvanized the movement. Hundreds of protesters gathered outside the courthouse Monday, carrying signs with slogans like “Roundup Kills” and “Protect Our Kids.” Speakers at the rally framed the case as a test of MAHA’s political clout, warning that a ruling favoring Bayer could undermine the group’s credibility with its base.
A Farm Bill Complicates the Alliance
While the Supreme Court deliberates, Congress is moving forward with legislation that could further entrench glyphosate’s legal protections. The farm bill, a sprawling agricultural policy measure expected to pass the House this week, includes provisions that would prevent states from imposing labeling requirements stricter than those set by the EPA. Critics, including MAHA supporters, argue that the bill would effectively immunize pesticide manufacturers from future lawsuits.
The farm bill’s glyphosate provisions have exposed a rift between Trump and his MAHA allies. Trump, who has long supported deregulation and agricultural interests, has signaled his intent to sign the bill if it reaches his desk. Kennedy, meanwhile, has publicly urged the president to veto the measure, setting up a potential showdown within the administration.
The tension comes at a delicate moment for Trump, who relies on MAHA’s grassroots network to mobilize voters ahead of the 2026 midterms. Some Republican lawmakers have privately expressed concern that the glyphosate debate could alienate the movement’s supporters, who have become a key voting bloc in swing states like Michigan and Wisconsin.
What’s Next for Glyphosate—and MAHA
The Supreme Court’s decision, expected by late June, will have far-reaching implications. If the justices rule in Bayer’s favor, it could curtail state-level lawsuits over other widely used chemicals, from PFAS (“forever chemicals”) to neonicotinoids, a class of pesticides linked to declining bee populations. A ruling against Bayer, yet, could embolden plaintiffs’ attorneys and lead to a wave of new litigation.
For MAHA, the case represents a critical test of its ability to shape policy beyond the election cycle. The movement has already notched victories, including the EPA’s 2025 decision to restrict glyphosate use in public parks and near schools. But its leaders acknowledge that a Supreme Court loss would force a strategic pivot, potentially shifting focus from litigation to legislative and regulatory battles.
As the legal and political fights unfold, one thing is clear: glyphosate has become more than just a weed killer. It’s now a symbol of the broader debate over chemical safety, corporate accountability, and the limits of federal regulation—a debate that will continue long after the Supreme Court issues its ruling.
Frequently Asked Questions
What is glyphosate?
Glyphosate is a broad-spectrum herbicide used to kill weeds and grasses. It is the active ingredient in Roundup, one of the most widely used agricultural chemicals in the world. Glyphosate works by inhibiting a specific enzyme pathway found in plants but not in animals, which is why it is often marketed as safe for humans when used as directed.
Why is glyphosate controversial?
The controversy stems from conflicting scientific assessments of glyphosate’s safety. The EPA maintains that glyphosate is not likely to cause cancer when used according to label instructions. However, the International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as “probably carcinogenic” in 2015, citing limited evidence of a link to non-Hodgkin lymphoma in humans. This discrepancy has fueled lawsuits and public distrust of the chemical.
What does the farm bill have to do with glyphosate?
The farm bill includes language that would preempt states from imposing labeling or safety requirements stricter than those set by the EPA. Critics argue this would prevent states from banning glyphosate or requiring additional warnings on Roundup products. Supporters say the measure is necessary to provide regulatory certainty for farmers and chemical manufacturers.
How has the Trump administration responded to MAHA’s concerns?
The administration has sent mixed signals. While Trump has not publicly commented on the Supreme Court case, his EPA has taken steps to restrict glyphosate use in certain settings, such as public parks. Meanwhile, Kennedy has been a vocal advocate for reducing glyphosate exposure, clashing with agricultural groups and some Republican lawmakers. The farm bill’s glyphosate provisions have further strained the administration’s relationship with MAHA.
What happens if the Supreme Court rules in favor of Bayer?
A ruling in Bayer’s favor would likely bar most state-level lawsuits alleging that glyphosate causes cancer. Plaintiffs would still be able to sue under federal law, but such cases are typically harder to win. The decision could also set a precedent for other chemicals, making it more difficult for consumers to hold manufacturers accountable for alleged harm.